See also this year's filing and all EDGAR filings for this company.
PDF Report 0001419041_2022_Forte_Biosciences_Inc.pdf
Logs
| warning | Missing logo | subcommand.report | {} |
| info | Failed to set obs_EconomicCapitalRatio | industry.us_generic | {'reason': "KeyError('0001419041')"} |
Graph
Absolute values for 0001419041, Forte Biosciences Inc.
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 42,520,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 0 |
| 2 | PropertyPlantAndEquipmentNet | 0 |
| 3 | remainder_Assets | 786,000 |
| 4 | LiabilitiesCurrent | 1,758,000 |
| 5 | LiabilitiesNoncurrent | 0 |
| 6 | remainder_Liabilities | 0 |
| 7 | CostOfGoodsAndServicesSold | 0 |
| 8 | SellingGeneralAndAdministrativeExpense | 7,633,000 |
| 9 | ResearchAndDevelopmentExpense | 13,853,000 |
| 10 | remainder_Expenses | 0 |
| 11 | remainder_Revenues | 0 |
| 12 | remainder_NetIncome | -222,000 |
| 13 | remainder_ComprehensiveNetIncome | 0 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 43,306,000 |
| 1 | Liabilities | 1,758,000 |
| 2 | Expenses | 21,486,000 |
| 3 | Revenues | 0 |
| 4 | StockholdersEquity | 41,548,000 |
| 5 | NetIncome | -21,708,000 |
| 6 | ComprehensiveNetIncome | -21,708,000 |
| 7 | BaseVar | 33,386,000 |
| 8 | EconomicCapitalRatio | 2.21 |